公司概覽
業務類別 Medical Devices
業務概覽 Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recoverysegment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
公司地址 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
電話號碼 +1 302 252-9160
傳真號碼 +1 800 936-6569
公司網頁 https://www.enovis.com
員工數量 7802
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Phillip Benjamin Berry Senior Vice President and Chief Financial Officer 美元 586.25K 26/02/2026
Ms. Patricia A. Lang Senior Vice President and Chief Human Resources Officer 美元 492.50K 26/02/2026
Mr. Terry D. Ross Group President, Prevention and Recovery -- 26/02/2026
Mr. Damien McDonald Chief Executive Officer and Director -- 26/02/2026
Mr. John Kleckner Vice President, Controller and Chief Accounting Officer -- 26/02/2026
Mr. Bradley J. Tandy Senior Vice President and Chief Legal Officer 美元 492.50K 26/02/2026
Ms. Laura Singleton Vice President, Human Resources -- 15/12/2025
Mr. Louie Vogt Group President, Reconstructive -- 26/02/2026
Mr. Oliver Engert Chief Administrative Officer -- 26/02/2026
 
董事會成員
董事會 職務 更新日期
Ms. Angela S. Lalor Independent Director 26/02/2026
Ms. Sharon L. Wienbar Chairman of the Board 26/02/2026
Mr. Damien McDonald Chief Executive Officer and Director 26/02/2026
Mr. Philip A. Okala Independent Director 26/02/2026
Mr. Brady R. Shirley Director 26/02/2026
Ms. Barbara W. Bodem Independent Director 26/02/2026
Mr. Liam J. Kelly Independent Director 26/02/2026
Mr. Rajiv Vinnakota Independent Director 26/02/2026
Mr. A. Clayton Perfall Independent Director 26/02/2026
Dr. Christine Ortiz, B.S.,M.S.,PhD Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:48)
代號 名稱 佔比% 持有日期
DFUSDimensional US Equity Market ETF0.01%27/02/2026
XJRiShares ESG Select Scrn S&P Small-CapETF0.01%28/02/2026
ACSVAmerican Century Small Cp Val Insgts ETF0.01%28/02/2026
DCORDimensional US Core Equity 1 ETF0.01%27/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
UWMProShares Ultra Russell20000.01%27/02/2026
URTYProShares UltraPro Russell20000.01%27/02/2026
WSMLiShares MSCI World Small-Cap ETF0.01%28/02/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.01%28/02/2026
RUSCRussell Inv U.S. Small Cap Equity ETF0.005%28/02/2026
ITWOProShares Russell 2000 High Income ETF0.004%27/02/2026
ISCBiShares Morningstar Small-Cap ETF0.004%28/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
ESSCEventide Small Cap ETF0.004%27/02/2026
DXUVDimensional US Vector Equity ETF0.004%27/02/2026
GABGabelli Equity Trust0.003%31/12/2025
DFSUDimensional US Sustainability Core 1 ETF0.003%27/02/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.002%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.002%25/02/2026
SAAProShares Ultra SmallCap6000.001%27/02/2026
  1    2   3    4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.